Viewing StudyNCT00179478



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00179478
Status: COMPLETED
Last Update Posted: 2017-09-06
First Post: 2005-09-12

Brief Title: Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
Sponsor: Beth Israel Deaconess Medical Center
Organization: Beth Israel Deaconess Medical Center

Organization Data

Organization: Beth Israel Deaconess Medical Center
Class: OTHER
Study ID: 2003P000086
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Beth Israel Deaconess Medical Center
Lead Sponsor Class: OTHER
Responsible Party: R Philip Kinkel
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Beth Israel Deaconess Medical Center
Old Name: None
Old Organization: None

Collaborators

Name Class
Biogen INDUSTRY